Structure Therapeutics Announces Multiple Upcoming Presentations at ObesityWeek® 2024

SAN FRANCISCO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and pulmonary diseases, today announced multiple upcoming posters at The Obesity Society's Annual Meeting, ObesityWeek^®, taking place from November 3-6, 2024 in San Antonio, TX.